Tugce Eskazan

4PUBLICATIONS
15CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 18, 2026
Prevalence of Latent and Active Tuberculosis Infection in Inflammatory Bowel Disease Patients Who Received Biological Treatment.

Saida Dashdamirova, Tugce Eskazan, Yusuf Ziya Erzin

|Dec 11, 2025
Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles.

Tugce Eskazan, Oguz Kagan Bakkaloglu, Murat Toruner

|Dec 03, 2021
Frequency, Predisposing Factors, and Clinical Outcome of Azathioprine-Induced Pancreatitis Among Patients With Inflammatory Bowel Disease: Results From a Tertiary Referral Center.

Tugce Eskazan, Selma Bozcan, Kadri Atay

|Oct 05, 2021
Can we predict mucosal remission in ulcerative colitis more precisely with a redefined cutoff level of C-reactive protein?

Oguz Kagan Bakkaloglu, Tugce Eskazan, Sinem Celik

Pageof 1

Frequent Collaborators

2 joint publications

Oguz Kagan Bakkaloglu

2 joint publications

Ali Ibrahim Hatemi

2 joint publications

Yusuf Ziya Erzin

1 joint publications

Murat Toruner